Youssef Bennani
Director/Board Member at BELLUS HEALTH
Profile
Youssef L.
Bennani is currently the Chief Executive Officer at Neurasic Therapeutics, Inc. He is also the Chairman at Domain Therapeutics Na, Inc., an Independent Director at BELLUS Health, Inc., a Director at Find Therapeutics, a Member at the Institute of Corporate Directors, the Chief Scientific Officer at adMare Bioinnovations, and the Managing Partner at CTI Life Sciences Fund.
Dr. Bennani's former positions include being the Chairman at Domain Therapeutics SA from 2014 to 2024.
He also held positions at Vertex Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., AbbVie, Inc., Athersys, Inc., and Neomed Institute.
From 2011 to 2017, he served as the Vice President-Research & Development, Site Head at Vertex Pharmaceuticals (Canada), Inc.Dr. Bennani's education includes a graduate degree from The Scripps Research Institute, a doctorate from the University of Montréal (conferred in 1991), and an MBA from Lake Forest Graduate School of Management (conferred in 2000).
Youssef Bennani active positions
| Companies | Position | Start |
|---|---|---|
| BELLUS HEALTH | Director/Board Member | 2017-04-30 |
| Domain Therapeutics Na, Inc. | Chairman | 2014-03-31 |
Neurasic Therapeutics, Inc.
 Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neurasic Therapeutics, Inc. develops opiate-sparing and pain-relieving drugs. The company was founded in June 2020 and is headquartered in Westmount, Canada. | Chief Executive Officer | - |
adMare Bioinnovations
 adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | - |
Find Therapeutics
 Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Chief Executive Officer | - |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Corporate Officer/Principal | - |
CTI Life Sciences Fund
 CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services CTI Life Sciences Fund provides life science related services. The private company is based in Montréal, Canada. The Canadian company was founded in 2006 by Kenneth Pastor. | Corporate Officer/Principal | 2021-04-30 |
Former positions of Youssef Bennani
| Companies | Position | End |
|---|---|---|
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Chairman | 2024-01-07 |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Youssef Bennani
| The Scripps Research Institute | Graduate Degree |
| University of Montréal | Doctorate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ABBVIE INC. | Health Technology |
| ATHERSYS, INC. | Health Technology |
| Private companies | 10 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Institute of Corporate Directors
Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Commercial Services |
Neomed Institute
 Neomed Institute Pharmaceuticals: OtherHealth Technology Neomed Institute operated as a non-profit organization for pharmaceutical companies. It offered analytical services, drug development, licensing, and drug discovery. The company was founded in 2012 and was headquartered in Montreal, Canada. | Health Technology |
Vertex Pharmaceuticals (Canada), Inc.
Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada. | Commercial Services |
adMare Bioinnovations
adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | |
| Domain Therapeutics Na, Inc. | |
Neurasic Therapeutics, Inc.
Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neurasic Therapeutics, Inc. develops opiate-sparing and pain-relieving drugs. The company was founded in June 2020 and is headquartered in Westmount, Canada. | Health Technology |
Find Therapeutics
Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Health Technology |
CTI Life Sciences Fund
CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services CTI Life Sciences Fund provides life science related services. The private company is based in Montréal, Canada. The Canadian company was founded in 2006 by Kenneth Pastor. | Commercial Services |
- Stock Market
- Insiders
- Youssef Bennani
